What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Immune system
- Gene
His primary areas of investigation include Immunology, Immune system, Antibody, Internal medicine and Endocrinology.
Immunology is often connected to Thymidine in his work.
His work deals with themes such as Lipopolysaccharide, Hematopoietic stem cell and Senescence, which intersect with Immune system.
His work investigates the relationship between Antibody and topics such as Antigen that intersect with problems in Virology and Peripheral blood mononuclear cell.
His work in the fields of Internal medicine, such as Alzheimer's disease, Age and gender, Age and sex and Healthy subjects, overlaps with other areas such as B2 receptor.
His research in Endocrinology tackles topics such as Cell which are related to areas like Histocompatibility, Erythrocyte rosetting and TCIRG1.
His most cited work include:
- Immunological studies of aging. Decreased production of and response to T cell growth factor by lymphocytes from aged humans. (401 citations)
- Impaired Lymphocyte Function in Aged Humans (301 citations)
- 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease (286 citations)
What are the main themes of his work throughout his whole career to date?
Marc E. Weksler mainly investigates Immunology, Antibody, Immune system, Molecular biology and Antigen.
His Immunology research includes elements of Internal medicine and Endocrinology.
The various areas that Marc E. Weksler examines in his Immune system study include Immunopathology and Ficoll.
His Molecular biology study combines topics from a wide range of disciplines, such as Cytotoxic T cell, In vitro, Gene expression, T cell and B cell.
His work carried out in the field of B cell brings together such families of science as Cell, Messenger RNA and Bone marrow.
In his study, which falls under the umbrella issue of Lymphocyte, Concanavalin A is strongly linked to Thymidine.
He most often published in these fields:
- Immunology (68.36%)
- Antibody (33.59%)
- Immune system (31.64%)
What were the highlights of his more recent work (between 2001-2016)?
- Immunology (68.36%)
- Antibody (33.59%)
- Disease (4.30%)
In recent papers he was focusing on the following fields of study:
Marc E. Weksler focuses on Immunology, Antibody, Disease, Immunotherapy and Internal medicine.
Immunology connects with themes related to Amyloid beta in his study.
As a part of the same scientific family, Marc E. Weksler mostly works in the field of Antibody, focusing on Amyloid and, on occasion, Beta, Normal level and Peptide.
His research in Disease intersects with topics in Etiology and Vaccination.
His Immunotherapy study integrates concerns from other disciplines, such as Alzheimer's disease, Biochemistry and Cerebrospinal fluid.
His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology, Humoral immunity and Endocrinology.
Between 2001 and 2016, his most popular works were:
- 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease (286 citations)
- Patients with Alzheimer disease have lower levels of serum anti-amyloid peptide antibodies than healthy elderly individuals (195 citations)
- Natural human antibodies to amyloid beta peptide (89 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Immune system
Marc E. Weksler spends much of his time researching Immunology, Antibody, Autoantibody, Internal medicine and Immune system.
His Immunology research is multidisciplinary, incorporating elements of Alzheimer's disease, Amyloid beta and Degenerative disease.
The study incorporates disciplines such as Antigen and Amyloid precursor protein in addition to Antibody.
His Autoantibody research is multidisciplinary, relying on both Tetanus, Toxoid and Immunity.
His Internal medicine research incorporates elements of Immunoglobulin E, Endocrinology and Intravenous Immunoglobulins.
The concepts of his Immune system study are interwoven with issues in Disease, Amyloid, Pathology, Normal level and Peptide.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
